Canadian consensus: inhibition of ALK-positive tumours in advanced non-small-cell lung cancer

Anaplastic lymphoma kinase (alk) is an oncogenic driver in non-small-cell lung cancer (nsclc). Chromosomal rearrangements involving the ALK gene occur in up to 4% of nonsquamous nsclc patients and lead to constitutive activation of the alk signalling pathway. ALK-positive nsclc is found in relativel...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Curr Oncol
Autors principals: Melosky, B., Agulnik, J., Albadine, R., Banerji, S., Bebb, D.G., Bethune, D., Blais, N., Butts, C., Cheema, P., Cheung, P., Cohen, V., Deschenes, J., Ionescu, D.N., Juergens, R., Kamel-Reid, S., Laurie, S.A., Liu, G., Morzycki, W., Tsao, M.S., Xu, Z., Hirsh, V.
Format: Artigo
Idioma:Inglês
Publicat: Multimed Inc. 2016
Matèries:
Practice Guideline
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4900831/
https://ncbi.nlm.nih.gov/pubmed/27330348
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3747/co.23.3120
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars